SPR Therapeutics LOGO 361 TM.jpg
Multi-Center Study of SPRINT® PNS System for Chronic Low Back Pain Demonstrates Clinically Significant Improvements in Pain and Quality of Life
July 12, 2021 08:00 ET | SPR Therapeutics, Inc.
CLEVELAND, July 12, 2021 (GLOBE NEWSWIRE) -- In the largest, most rigorous study to date using the SPRINT® PNS System for chronic axial low back pain (LBP), patients that failed to find relief from...
SPR Therapeutics LOGO 361 TM.jpg
Multi-center Study Demonstrates Significant Reductions in Postoperative Pain and Opioid Use Following Peripheral Nerve Stimulation Treatment
April 26, 2021 09:41 ET | SPR Therapeutics, Inc.
CLEVELAND, April 26, 2021 (GLOBE NEWSWIRE) -- Results of a multicenter trial recently published in Anesthesiology, the official peer-reviewed journal of the American Society of Anesthesiologists,...
SPR Therapeutics LOGO 361 TM.jpg
SPRINT® PNS System Demonstrates the Important Role of the Multifidus in Treating Recurrent Low Back Pain Following RFA
March 02, 2021 10:45 ET | SPR Therapeutics, Inc.
CLEVELAND, March 02, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of...
Aspero Medical completes animal clinical study and announces the formation of Clinical Advisory Board
December 29, 2020 10:24 ET | Innosphere Ventures
Boulder, Colorado, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing new products for the field of gastroenterology recently completed the company’s...
Grey Cloak Tech Inc. Announces Positive Results From a Clinical Study of Their Proprietary Womens HERHEART Product
December 03, 2020 08:30 ET | Grey Cloak Tech Inc
LAS VEGAS, NV, Dec. 03, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Grey Cloak Tech Inc. (OTCQB: GRCK) (soon to be Healthy Extracts Inc. pending their corporate name change), a company engaged in...
RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
August 11, 2020 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Norton Healthcare enrolls first patient in world for COVID-19 drug trial
April 21, 2020 10:04 ET | Norton Healthcare
Louisville, KY, April 21, 2020 (GLOBE NEWSWIRE) -- A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor....
Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020
March 30, 2020 06:05 ET | Cocrystal Pharma, Inc.
Advancing preclinical COVID-19 Coronavirus program leveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”) Continuing collaboration with Merck to discover...
Misonix Announces Results of New Large Real-World Studies That Further Prove the Clinical Effectiveness of TheraSkin
December 05, 2019 09:30 ET | MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Cognoa Launches Pivotal Study of the First Digital Diagnostic for Autism
October 24, 2019 09:00 ET | Cognoa
Palo Alto, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of pediatric behavioral health, announced today initiation of its Pivotal Study to demonstrate the...